Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Metabolism. 2008 May;57(5):718–724. doi: 10.1016/j.metabol.2008.01.018

Differential expression of hepatic genes involved in cholesterol homeostasis in high and low responding strains of laboratory opossums

Jeannie Chan a,b,*, Lisa M Donalson a,b, Rampratap S Kushwaha c, Sacha Ferdinandusse d, Jane F VandeBerg a,b, John L VandeBerg a,b
PMCID: PMC2465809  NIHMSID: NIHMS50000  PMID: 18442639

Abstract

Plasma very low density lipoprotein and low density lipoprotein (VLDL+LDL) cholesterol levels of two partially inbred strains of opossums (Monodelphis domestica) differ markedly when they are fed a high cholesterol and low fat (HCLF) diet. High responding opossums exhibit a dramatic increase (> 10-fold) in VLDL+LDL cholesterol whereas low responding opossums exhibit a minimal increase (< 2-fold) in VLDL+LDL cholesterol. The genes responsible for the accumulation of high levels of plasma VLDL+LDL cholesterol in high responding opossums have not yet been identified.

In this study, we analyzed the expression of genes encoding for 1) four bile acid synthesis enzymes (CYP7A1, CYP27A1, CYP8B1, and CYP7B1); 2) three cholesterol synthesis enzymes (HMGCR, HMGCS1, and SQLE); 3) the LDL receptor (LDLR); 4) two sterol transporters (ABCG5 and ABCG8); and 5) two bile acid transporters (ABCB11 and SLC10A1) to determine how the expression of these genes was affected by dietary cholesterol in the two strains of opossums. We found differences between high and low responders in the expression of cholesterol synthesis genes on the basal diet, as well as differences in the expression of the CYP27A1, ABCG5, ABCG8, and SLC10A1 genes on the HCLF diet. CYP27A1 mRNA levels were lower in the livers of high responders compared with low responders, whereas CYP27A1 mRNA levels in extrahepatic tissues were similar in high and low responders on the HCLF. Low levels of CYP27A1, ABCG5, and ABCG8 expression in the liver may contribute to hypercholesterolemia in high responding opossums.

Keywords: Dietary cholesterol, CYP27A1, Monodelphis domestica, opossum, hypercholesterolemia

1. Introduction

Two partially inbred strains of opossums (Monodelphis domestica) have been developed to study diet-induced hypercholesterolemia [1, 2]. In low responding opossums, diets enriched in cholesterol alone (HCLF), or enriched in cholesterol and fat (HCHF), have a minimal effect on plasma very low density lipoprotein and low density lipoprotein (VLDL+LDL) cholesterol [3]. In high responding opossums, in contrast, the HCLF diet induces a marked increase (>10-fold) in plasma VLDL+LDL cholesterol, and the HCHF diet induces even a greater increase (>30-fold) in plasma VLDL+LDL cholesterol [3]. However, a diet enriched in fat alone has little effect on plasma VLDL+LDL cholesterol in high or low responding opossums. [3].

Plasma cholesterol concentration is the balance of cholesterol absorption, cholesterol synthesis, and cholesterol excretion. Metabolic studies conducted to measure cholesterol absorption revealed that fractional cholesterol absorption was two-fold higher in high responders than in low responders fed the HCHF diet [4], and biochemical studies revealed that activity of the bile acid synthesis enzyme sterol 27-hydroxylase was lower in high responders fed the HCHF diet [5], suggesting differences in cholesterol absorption and bile acid synthesis contribute to increased plasma VLDL+LDL cholesterol in high responders. In this study, we examined the expression of genes in liver that are involved in the biosynthesis of bile acids or the biosynthesis of cholesterol as well as the expression of genes in liver that are involved in the transport of cholesterol or bile acids to investigate if there are differences in the expression patterns of these genes between high and low responding opossums after a dietary challenge.

2. Materials and methods

2.1. Animals and diets

The two partially inbred strains (ATHH and ATHE) of laboratory opossums (Monodelphis domestica) used for this investigation were produced at the Southwest Foundation for Biomedical Research (SFBR), and had inbreeding coefficients greater than 0.7. They were selectively bred for high and low responsiveness to dietary lipids. High responding opossums were from the ATHH strain, and low responding opossums were from the ATHE strain. Animals were maintained in polycarbonate cages under laboratory conditions as described previously [6]. Opossums were fed either the basal diet which contained 0.16% cholesterol (g/kg; dry weight basis) or the HCLF diet which had the same fat content as the basal diet but a cholesterol content of 0.71% [3].

The protocol of these experiments was approved by the Institutional Animal Care and Use Committee of the SFBR. The SFBR is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International, and is registered with the US Department of Agriculture.

2.2. Measurement of lipoprotein cholesterol and hepatic cholesterol

Plasma VLDL+LDL cholesterol was calculated as total cholesterol minus HDL cholesterol as described previously [3]. After consuming the HCLF diet for four weeks, plasma VLDL+LDL cholesterol of high responders in this study ranged from 273 to 389 mg/dl, whereas plasma VLDL+LDL cholesterol of low responders ranged from 19 to 40 mg/dl. Hepatic cholesterol was measured as described previously [4].

2.3. Measurement of bile acids

Bile acids were analyzed by HPLC negative ion electrospray tandem mass spectrometry as described [7]. Sample preparation for analysis of bile acids in plasma was performed as described [8]. For analysis of bile acids in bile, the bile was diluted 100 times in water.

2.4. Northern blot analysis

To study expression of the genes listed in Table 1, we cloned Monodelphis cDNAs of these genes. Human cDNAs were used as queries in discontiguous MegaBLAST searches against the Monodelphis whole genome sequence trace archive database, and primers were selected from Monodelphis sequences that aligned with human sequences using the online program Primer3 [http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi]. Monodelphis cDNAs were synthesized by reverse transcription-polymerase chain reaction using their respective forward and reverse primers (Table 1), and cloned into the pCR4-TOPO vector (Invitrogen, Carlsbad, CA). The cDNAs were sequenced on an ABI Prism 3100 DNA sequencer (Applied Biosystems, Foster City, CA), and their identities were verified by BLAST searches based on homology to sequences of human and other species.

Table 1.

Primer sequences and accession numbers

Gene Forward primer (5′ - 3′) Reverse primer (5′ - 3′) Accession
Number
CYP7A1 AGGCGAATGGGAGAGCCAC AAACTCGATATCATTTGTTGGTG EF599652
CYP8B1 CAGGCGTTATGGGAACATCT ACCACCAGGCGTAATGTCTC EF599651
CYP27A1 TGGAGCAGCTGCTGAGGCAG AGAGTTTCCTTAAGCACTGCTTTG EF601083
CYP7B1 AGACCTGGGGAGCCTCCTT GCTGTCCATTGTTCTCTGGTGA EF599114
HMGCR ATGTTGTCAAGACTCTTCCGAAT CTTGGAAAGATAAAATTGCCAGA EF599116
HMGCS1 AGGACTTCGTGGGACACACAT GCTGCTTCAGGTTCTGCTGT EF599117
SQLE GGCCTTGATGCCCATGTT TCATCATAAAGATCAGGGATGC EF599115
LDLR GGGAATATGACTGCAAGGACAT AAGCCATGAACAGGATCCAC AY871266
ABCG5 ATGTTGTTCGATGAGCCAACC AATCCAGACCCAACAAGGATG EF599647
ABCG8 TCCAGGACAGTGTGTTCCTCTC AGAAGTCCGCAGGATTGCTA EF599648
ABCB11 TTCTTTTAAGTTTCGATTTTCTTCA GTGAATATTCGCCTTCTTCCA EF601084
SLC10A1 CAGCATTGTGATGACCACCT CCTTGGGAGTCTTGATTTTATTG EF599649
GAPDH AAGGGCACTGTAAAGGCAGA AGAAGAGTGGGTGTCGCTGT EF599650

Tissues were collected from animals fed the basal diet or from animals fed the HCLF diet for four weeks. Livers, lungs, and kidneys were quickly cut into small pieces and snap-frozen in liquid nitrogen. The small intestine was divided into six equal segments, the mucosa was scraped from the third segment from the proximal end and snap-frozen. Total RNA was isolated from frozen, pulverized tissues using TRI Reagent (Molecular Research Center, Cincinnati, OH) according to the manufacturer's instructions. RNA was quantified using an ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). Total RNA (4 μg) from each sample was fractionated by electrophoresis on 1% agarose-formaldehyde gels, and transferred to Hybond-XL membranes (Amersham Biosciences, Piscataway, NJ).

Probes were synthesized by amplifying the cDNA insert from each clone with gene-specific primers, and the PCR products were labeled with [α-32P]dCTP (3000 Ci/mmol; Perkin Elmer, Shelton, CT) using a megaprime DNA labeling kit (Amersham Biosciences). Blots were hybridized with radiolabeled cDNA probes in ULTRAhyb (Ambion, Austin, TX) according to the manufacturer's instructions. After an overnight hybridization at 42°C, blots were washed once in 2X SSC at 42°C for 5 min, once in 2X SSC at 65°C for 10 min, and twice in 0.2X SSC at 65°C for 20 min. After washing, blots were exposed to BioMax MR films (Kodak, Rochester, NY) or to phosphor screens to quantify the hybridization signals using the Storm 840 Imaging System (Amersham Biosciences). To correct for differences in the amount of RNA loaded on the gels or transferred to membranes, blots were stripped of the labeled probes by washing in 0.1% SDS at 80°C for 15 min, and probed with radiolabeled glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA. All quantifications of gene expression were normalized to the GAPDH hybridization signal.

2.5. Statistical analysis

Results are expressed as mean ± S.D. Statistical significance was determined with Student's t-test. A value of P < 0.05 was considered significant.

3. Results

3.1. Expression of bile acid synthesis genes

We examined the expression of four bile acid synthesis genes to investigate if any of these genes were affected by dietary cholesterol in high and low responders. The first gene was CYP7A1. The CYP7A1 gene encodes cholesterol 7α-hydroxylase, which is the first and rate-limiting enzyme in the classic pathway [9]. The classic pathway is the major pathway for bile acid synthesis in the liver [9]. Variable expression of CYP7A1 mRNA was observed in the two strains of opossums on the basal diet (Fig. 1A) as well as on the HCLF diet (Fig. 1B), and there was no difference in CYP7A1 mRNA expression between high and low responders on the basal and HCLF diets.

Fig. 1.

Fig. 1

Expression of genes encoding for enzymes in bile acid synthesis. Northern blots of total RNA (4 μg) from high and low responding opossums fed the basal (A) or HCLF diet (B) were hybridized with 32P-labeled cDNA probes. mRNA levels were quantified as described in the Materials and methods section. Expression of CYP27A1 on the HCLF diet (B) was significantly lower (P < 0.0001) in high responders (17.7 ± 6.63 units) compared with low responders (74.1 ± 11.7 units). The CYP7A1 gene encodes cholesterol 7α-hydroxylase, CYP8B1 gene encodes sterol 12α-hydroxylase, CYP27A1 gene encodes sterol 27-hydroxylase, and CYP7B1 gene encodes oxysterol 7α-hydroxylase.

The second gene was CYP8B1. The CYP8B1 gene encodes sterol 12α-hydroxylase, which is the third enzyme in the classic pathway. Sterol 12α-hydroxylase produces 12α-hydroxylated intermediates for cholic acid synthesis, and thereby determines the ratio of cholic acid to chenodeoxycholic acid in the composition of bile acids [9]. Two of the low responders appeared to have higher CYP8B1 mRNA levels than those in high responders on the HCLF diet (Fig. 1B), but the difference in CYP8B1 expression between high and low responders was not statistically significant.

The third gene was CYP27A1. The CYP27A1 gene encodes sterol 27-hydroxylase, which initiates bile acid synthesis in the alternate pathway to produce 27-hydroxycholesterol [9]. In addition, sterol 27-hydroxylase catalyzes oxidation of the steroid side chain in later steps of the classic and alternate biosynthesis pathways [9]. There was no difference in CYP27A1 expression on the basal diet (Fig. 1A), but CYP27A1 mRNA was expressed 4-fold higher (P < 0.0001) in low responders (74.1 ± 11.7 units) compared with high responders (17.7 ± 6.33 units) on the HCLF diet (Fig. 1B).

The fourth gene was CYP7B1. The CYP7B1 gene encodes oxysterol 7α-hydroxylase, the enzyme that hydroxylates 27-hydroxycholesterol at the 7α position in the second step of the alternate pathway [9]. CYP7B1 mRNA was expressed at very low levels in high and low responders on the HCLF diet (Fig. 1B), and similar levels of CYP7B1 mRNA were detected in high and low responders.

In another experiment, we compared CYP27A1 mRNA levels in opossums fed the HCLF diet with those in opossums fed the basal diet to determine how CYP27A1 expression was affected by a cholesterol-enriched diet. The HCLF diet had little effect on CYP27A1 expression in low responders, but down-regulated CYP27A1 expression in high responders such that high responders fed the HCLF diet had the lowest level of CYP27A1 mRNA compared with other groups of opossums (Fig. 2A). Analysis of bile acids in the gall bladder revealed that the composition of bile acids in high responders was similar to that in low responders (data not shown), indicating that there is no defect in the biosynthesis of bile acids in high responders.

Fig. 2.

Fig. 2

Expression of the CYP27A1 gene in liver and extrahepatic tissues. (A) High and low responding opossums were fed the basal or HCLF diet. Total RNA isolated from the liver was subjected to electrophoresis on a formaldehyde-agarose gel, and analyzed by Northern blotting with a 32P-labeled CYP27A1 probe. After stripping the CYP27A1 probe, the membrane was hybridized with a 32P-labeled GAPDH probe. mRNA levels were quantified as described in the Materials and methods section. (B) Northern blots of total RNA from different tissues of high and low responders fed the HCLF diet were hybridized with a 32P-labeled CYP27A1 probe.

The CYP27A1 gene is also expressed in extrahepatic tissues [10-12], so we examined CYP27A1 expression in small intestines, lungs, and kidneys of high and low responders fed the HCLF diet to determine if the pattern of gene expression in extrahepatic tissues was the same as that in the liver. We collected livers and extrahepatic tissues from another four high responders and four low responders. As shown in Fig. 2B, high and low responders differed in CYP27A1 expression in the liver which is consistent with the results in Fig. 1B, but the difference in CYP27A1 expression was not detected in small intestine, lung, and kidney.

3.2. Expression of cholesterol synthesis genes

We investigated the effect of dietary cholesterol on the expression of cholesterol synthesis genes in high and low responders. The major rate-limiting enzyme in cholesterol synthesis is HMG-CoA reductase. Mevalonic acid, the precursor of cholesterol, is synthesized from acetyl-CoA by two enzymes, HMG-CoA synthase and HMG-CoA reductase. HMG-CoA synthase catalyzes the production of the intermediate HMG-CoA from acetyl-CoA, and HMG-CoA reductase catalyzes the formation of mevalonic acid from HMG-CoA [13, 14]. Squalene epoxidase, the enzyme that catalyzes the oxidation of squalene is the secondary rate-limiting enzyme in cholesterol synthesis [15]. To determine if dietary cholesterol affects endogenous cholesterol synthesis in high and low responders, we measured mRNA levels of the genes encoding HMG-CoA reductase (HMGCR), HMG-CoA synthase (HMGCS1), and squalene epoxidase (SQLE) in opossums fed the basal or high cholesterol diet. We also measured LDL receptor (LDLR) mRNA levels because LDLR expression is regulated by the sterol regulatory element-binding protein-2, the same transcription factor that regulates expression of cholesterol synthesis genes [16].

In opossums fed the basal diet, HMGCR (56.5 ± 20.8 units for low responders vs. 18.3 ± 11.1 units for high responders; P = 0.007) and SQLE (5.96 ± 2.35 units for low responders vs. 1.03 ± 0.66 units for high responders; P = 0.002) mRNAs were expressed at higher levels in low responders than in high responders (Fig. 3A). HMGCS1 expression varied among low responders, and one high responder expressed a high level of HMGCS1 mRNA (Fig. 3A). Despite variability in HMGCS1 expression within the two groups of opossums, the average HMGCS1 mRNA level was higher in low responders (19.5 ± 9.7 units for low responders vs. 4.2 ± 2.9 units for high responders; P = 0.01). LDLR mRNA expression did not show a significant difference in high and low responders (Fig. 3A).

Fig. 3.

Fig. 3

Northern blots showing expression of the HMG-CoA reductase gene (HMGCR), HMG-CoA synthase gene (HMGCS1), squalene epoxidase gene (SQLE), and the low density lipoprotein receptor gene (LDLR). Total RNA from high and low responding opossums fed the basal (A) or HCLF diet (B) were hybridized with 32P-labeled cDNA probes. mRNA levels were quantified as described in the Materials and methods section. HMGCR (56.5 ± 20.8 units for low responders vs. 18.3 ± 11.1 units for high responders; P = 0.007), HMGCS1 (19.5 ± 9.7 units for low responders vs. 4.2 ± 2.9 units for high responders; P = 0.01), and SQLE (5.96 ± 2.35 units for low responders vs. 1.03 ± 0.66 units for high responders; P = 0.002) mRNAs were expressed significantly higher in low responders compared with high responders on the basal diet.

Plasma VLDL+LDL cholesterol concentrations of high and low responders do not differ on the basal diet [2, 3]. Measurement of cholesterol in the liver revealed hepatic cholesterol concentrations were slightly elevated in high responders (3.61 ± 0.15 mg/g liver for high responders vs. 2.81 ± 0.53 mg/g liver for low responders; P = 0.012). Therefore, lower mRNA levels of the cholesterol biosynthesis genes in high responders reflect endogenous cholesterol synthesis is suppressed to maintain normal concentrations of plasma cholesterol.

When the diet was changed to one enriched with cholesterol, hepatic cholesterol was increased in low responders (2.81 ± 0.53 mg/g liver on basal diet vs. 4.34 ± 0.42 mg/g liver on HCLF diet) as well as in high responders (3.61 ± 0.15 mg/g liver on basal diet vs. 8.86 ± 2.74 mg/g liver on HCLF diet), and the increase was greater in high responders. HMGCR expression was hardly detectable in high and low responders fed the HCLF diet (Fig. 3B), implying that endogenous cholesterol is synthesized at a very low rate to counteract the increase in hepatic cholesterol. HMGCS1, SQLE, and LDLR mRNAs were also expressed at very low levels in all of the high responders (Fig. 3B). However, there were two distinct patterns of expression of these genes in low responders. The HMGCS1, SQLE, and LDLR genes were coordinately down-regulated in two of the five low responders. Plasma VLDL+LDL cholesterol in these two low responders (27 mg/dl and 40 mg/dl) was slightly higher than that in the other three low responders (∼19 mg/dl), which may explain the difference in expression of the HMGCS1, SQLE, and LDLR genes.

3.3. Expression of sterol transporter genes

The ATP-Binding Cassette (ABC) transporter genes, ABCG5 and ABCG8, encode proteins that are involved in sterol transport [17, 18]. ABCG5 and ABCG8 are half-size transporters that dimerize to form a functional transporter at the apical membrane of liver to remove sterol from the liver into bile [19, 20]. We investigated if expression of the ABCG5 and ABCG8 genes differed between the two strains of opossums on the HCLF diet. Lower levels of ABCG5 (19.9 ± 5.4 units for high responders vs. 45.8 ± 14.3 units for low responders; P = 0.005) and ABCG8 (7.9 ± 2.8 units for high responders vs. 12.7 ± 2.8 units for low responders; P = 0.026) mRNAs were detected in high responders compared with low responders (Fig. 4).

Fig. 4.

Fig. 4

Expression of sterol transporter genes (ABCG5 and ABCG8) and bile acid transporter genes (ABCB11 and SLC10A1). Northern blots of total RNA (4 μg) from high and low responders fed the HCLF diet were hybridized with 32P-labeled cDNA probes. mRNA levels were quantified as described in the Materials and methods section. ABCG5 (19.9 ± 5.4 units for high responders vs. 45.8 ± 14.3 units for low responders; P = 0.005), ABCG8 (7.9 ± 2.8 units for high responders vs. 12.7 ± 2.8 units for low responders; P = 0.026), and SLC10A1 (16.4 ± 14.2 units for high responders vs. 54.8 ± 20.8 units for low responders; P = 0.009) mRNAs were expressed significantly lower in high responders compared with low responders.

3.4. Expression of bile salts transporter genes

After bile salts are synthesized in the liver, they are first secreted into the bile canaliculi by the bile salt export pump, then secreted into the intestinal lumen. Eventually most of the excreted bile acids are reabsorbed in the lower intestine and go to the hepatic portal circulation. Finally, uptake of most of the conjugated bile acids and some of the unconjugated bile acids from the portal circulation back to hepatocytes is mediated by the sodium-taurocholate cotransporting protein to complete the enterohepatic circulation of bile salts [21, 22].

We analyzed expression of the ABCB11 gene, which encodes the bile salt export pump. The bile salt export pump mediates the excretion of taurine- or glycine-conjugated bile salts from hepatocytes [21, 22]. Northern blots showed very weak signals for ABCB11 expression, and there was no consistent difference in ABCB11 mRNA levels between high and low responding opossums on the HCLF diet (Fig. 4).

We also analyzed expression of the SLC10A1 gene, which encodes the sodium-taurocholate cotransporting protein. As shown in Fig. 4, high responders expressed lower levels of SLC10A1 mRNA (16.4 ± 14.2 units for high responders vs. 54.8 ± 20.8 units for low responders; P = 0.009). Analysis of bile acids in plasma revealed that the levels were markedly elevated in the plasma of high responders (205 - 480 μmol/L) relative to those in low responders (12 - 58 μmol/L). The difference was predominantly caused by increased levels of the mature bile acids, tauro-cholic acid and tauro-chenodeoxycholic acid. Decreased SLC10A1 expression in high responders may reduce the uptake of bile acids from the hepatic portal circulation, and lead to an accumulation of bile acids in plasma.

4. Discussion

High and low responding laboratory opossums were developed to study the effect of dietary cholesterol on plasma lipoprotein cholesterol. To investigate how some of the important hepatic genes that control cholesterol homeostasis respond to dietary cholesterol in the opossum model, we compared their expression in high and low responding opossums by Northern blot analysis. A notable difference is the expression of the CYP27A1 gene, which was down-regulated in the livers of high responders after they were fed a high cholesterol diet, but the same diet had little effect on CYP27A1 expression in low responders (Fig. 2A). The CYP27A1 gene encodes the mitochondrial enzyme sterol 27-hydroxylase which is expressed in a wide variety of tissues. In the liver, sterol 27-hydroxylase catalyzes several reactions in bile acid synthesis [9]. Therefore, decreased expression of the CYP27A1 gene may impede synthesis and excretion of bile acids in high responders. Sterol 27-hydroxylase is also expressed in extrahepatic tissues where it converts cholesterol to 27-hydroxycholesterol or 3β-hydroxy-5-cholestenoic acid. The 27-oxygenated products are then transported to the liver where they are metabolized to bile acids [23, 24]. Northern blots showed that in kidney, lung, and intestine, high and low responders had similar levels of CYP27A1 expression, which was different from the pattern expressed in liver (Fig. 2B). Thus, in high responders, the effect of dietary cholesterol on CYP27A1 expression in the liver was different from that in extrahepatic tissues.

Another difference is the expression of the ABCG5 and ABCG8 genes in opossums fed the HCLF diet. Repa et al. [25] reported that ABCG5 and ABCG8 mRNAs were up-regulated by cholesterol feeding in mice, and the response was mediated by the ligand-activated transcription factor liver X receptor (LXR). The naturally occurring ligands for LXR are oxysterols. One of the oxysterols that activates LXR is 27-hydroxycholesterol, which is produced from cholesterol by sterol 27-hydroxylase. It is conceivable that lower levels of ABCG5 and ABCG8 mRNAs in high responders reflect lower levels of 27-hydroxycholesterol because of lower levels of CYP27A1 mRNA in high responders. Lower ABCG5 and ABCG8 expression implies less cholesterol is secreted into bile, so excess cholesterol accumulates in the livers of high responders.

A third difference is lower expression of the bile salt transporter gene SLC10A1 in high responders. The sodium-taurocholate cotransporting protein encoded by the SLC10A1 gene is expressed at the basolateral membrane of hepatocytes and extracts bile acids from the portal circulation back to the liver [21, 22]. SLC10A1 mRNA expression in the liver has been shown to be down-regulated by the retention of biliary constituents in bile-obstructed rats as a defense mechanism to protect the liver against toxic bile acids [26]. High plasma levels of bile acids are most likely due to low SLC10A1 expression in high responders.

Plasma cholesterol response to dietary cholesterol and fat differs considerably among species and among individuals of the same species including humans. A number of animal species such as rabbits [27], mice [28], rats [29], rhesus monkeys [30], baboons [31, 32] and humans [33, 34] also exhibit individual variability in lipoprotein cholesterol in response to dietary cholesterol. Increased cholesterol absorption has been suggested to be a possible mechanism for high and low responsiveness to dietary lipids in some animals and humans [35]. Our previous studies have demonstrated that high responding opossums as compared to low responding opossums have a two-fold higher percent cholesterol absorption on a cholesterol and fat enriched diet [4]. Several genes (ABCG5, ABCG8, ACAT2, NPC1L1, SR-BI, and CD36) play a role in intestinal cholesterol absorption [36, 37]. The expression pattern of these genes in the intestines of high and low responding opossums will be reported in a separate manuscript. The present studies were conducted to determine whether high and low responding opossums differ in the expression of hepatic cholesterol responsive genes and thus hepatic cholesterol metabolism on the high cholesterol diet. The results clearly demonstrate that high responding opossums as compared to low responding opossums express lower levels of four genes (CYP27A1, ABCG5, ABCG8 and SLC10A1) that affect hepatic cholesterol and bile acid metabolism. Similar studies were conducted in high and low responding baboons that were produced by selective breeding based on variability in LDL cholesterol to a high cholesterol and high fat diet [31, 32]. In the baboon model, high responding baboons have moderately elevated LDL cholesterol. High responding baboons also express lower levels of CYP27A1, ABCG5 and ABCG8 mRNAs in their livers compared with low responding baboons after the dietary challenge [32, 38]. However, there is a difference in the regulation of CYP27A1 expression between baboons and opossums. The difference in CYP27A1 expression in the baboon model is due to up-regulation of the CYP27A1 gene to higher levels in low responding baboons relative to those in high responding baboons [32], whereas the difference in CYP27A1 expression in the opossum model is due to down-regulation of the CYP27A1 gene in high responding opossums while CYP27A1 gene expression is not affected by the high cholesterol diet in low responding opossums. The genes that control responsiveness to dietary cholesterol in opossums and baboons may be different, and have not yet been identified. Thus, the opossum and baboon models provide an opportunity for a comparative study of the genetic basis of variation in the responsiveness of lipoprotein cholesterol to dietary cholesterol.

In conclusion, the CYP27A1, ABCG5, ABCG8, and SLC10A1 genes were expressed at lower levels in high responding opossums compared with low responding opossums on the HCLF diet. Down-regulation of the CYP27A1 gene may affect ABCG5 and ABCG8 expression, and contribute to the accumulation of plasma VLDL+LDL cholesterol and hepatic cholesterol. Down-regulation of the SLC10A1 gene may contribute to the accumulation of bile acids in plasma.

Acknowledgments

This study was supported by NIH grant R01 DK65058, by a grant from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, and by the Netherlands Organisation for Scientific Research (NWO grant 916.46.109). The authors thank Janice MacRossin, Roxanne Rodriguez, and Henny Rusch for technical assistance.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.VandeBerg JL, Cheng ML. Dyslipoproteinemia in a laboratory marsupial, Monodelphis domestica. Isozyme Bull. 1985;18:66. [Google Scholar]
  • 2.Rainwater DL, VandeBerg JL. Dramatic differences in lipoprotein composition among gray short-tailed opossums (Monodelphis domestica) fed a high cholesterol/saturated fat diet. Biochim Biophys Acta. 1992;1126:159–66. doi: 10.1016/0005-2760(92)90286-5. [DOI] [PubMed] [Google Scholar]
  • 3.Kushwaha RS, VandeBerg JF, VandeBerg JL. Effect of dietary cholesterol with or without saturated fat on plasma lipoprotein cholesterol levels in the laboratory opossum (Monodelphis domestica) model for diet-induced hyperlipidaemia. Br J Nutr. 2004;92:63–70. doi: 10.1079/BJN20041167. [DOI] [PubMed] [Google Scholar]
  • 4.Kushwaha RS, VandeBerg JF, Rodriguez R, et al. Cholesterol absorption and hepatic acyl-coenzyme A:cholesterol acyltransferase activity play major roles in lipemic response to dietary cholesterol and fat in laboratory opossums. Metabolism. 2004;53:817–22. doi: 10.1016/j.metabol.2003.12.029. [DOI] [PubMed] [Google Scholar]
  • 5.Kushwaha RS, VandeBerg JF, Jackson EM, et al. High and low responding strains of laboratory opossums differ in sterol 27-hydroxylase and acyl-coenzyme A:cholesterol acyltransferase activities on a high cholesterol diet. J Nutr Biochem. 2001;12:664–73. doi: 10.1016/s0955-2863(01)00183-8. [DOI] [PubMed] [Google Scholar]
  • 6.VandeBerg JL. The laboratory opossum (Monodelphis domestica) In: Poole T, English P, editors. UFAW Handbook on the Management of Laboratory Animals, 7th edition, vol 1: Terrestrial Vertebrates. Blackwell Science Ltd; Oxford, UK: 1999. pp. 193–209. [Google Scholar]
  • 7.Ferdinandusse S, Denis S, Overmars H, et al. Developmental changes of bile acid composition and conjugation in L- and D-bifunctional protein single and double knockout mice. J Biol Chem. 2005;280:18658–66. doi: 10.1074/jbc.M414311200. [DOI] [PubMed] [Google Scholar]
  • 8.Bootsma AH, Overmars H, van Rooij A, et al. Rapid analysis of conjugated bile acids in plasma using electrospray tandem mass spectrometry: application for selective screening of peroxisomal disorders. J Inherit Metab Dis. 1999;22:307–10. doi: 10.1023/a:1005543802724. [DOI] [PubMed] [Google Scholar]
  • 9.Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003;72:137–74. doi: 10.1146/annurev.biochem.72.121801.161712. [DOI] [PubMed] [Google Scholar]
  • 10.Andersson S, Davis DL, Dahlback H, et al. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem. 1989;264:8222–9. [PubMed] [Google Scholar]
  • 11.Reiss AB, Martin KO, Rojer DE, et al. Sterol 27-hydroxylase: expression in human arterial endothelium. J Lipid Res. 1997;38:1254–60. [PubMed] [Google Scholar]
  • 12.Li T, Chen W, Chiang JY. PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. J Lipid Res. 2007;48:373–84. doi: 10.1194/jlr.M600282-JLR200. [DOI] [PubMed] [Google Scholar]
  • 13.Sato R, Takano T. Regulation of intracellular cholesterol metabolism. Cell Struct Funct. 1995;20:421–7. doi: 10.1247/csf.20.421. [DOI] [PubMed] [Google Scholar]
  • 14.Istvan ES, Deisenhofer J. The structure of the catalytic portion of human HMG-CoA reductase. Biochim Biophys Acta. 2000;1529:9–18. doi: 10.1016/s1388-1981(00)00134-7. [DOI] [PubMed] [Google Scholar]
  • 15.Chugh A, Ray A, Gupta JB. Squalene epoxidase as hypocholesterolemic drug target revisited. Prog Lipid Res. 2003;42:37–50. doi: 10.1016/s0163-7827(02)00029-2. [DOI] [PubMed] [Google Scholar]
  • 16.Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109:1125–31. doi: 10.1172/JCI15593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 2000;290:1771–5. doi: 10.1126/science.290.5497.1771. [DOI] [PubMed] [Google Scholar]
  • 18.Lu K, Lee MH, Hazard S, et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet. 2001;69:278–90. doi: 10.1086/321294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Graf GA, Li WP, Gerard RD, et al. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest. 2002;110:659–69. doi: 10.1172/JCI16000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Yu L, Li-Hawkins J, Hammer RE, et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest. 2002;110:671–80. doi: 10.1172/JCI16001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev. 2003;83:633–71. doi: 10.1152/physrev.00027.2002. [DOI] [PubMed] [Google Scholar]
  • 22.Pauli-Magnus C, Stieger B, Meier Y, et al. Enterohepatic transport of bile salts and genetics of cholestasis. J Hepatol. 2005;43:342–57. doi: 10.1016/j.jhep.2005.03.017. [DOI] [PubMed] [Google Scholar]
  • 23.Bjorkhem I, Andersson O, Diczfalusy U, et al. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci U S A. 1994;91:8592–6. doi: 10.1073/pnas.91.18.8592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Pikuleva IA, Babiker A, Waterman MR, et al. Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways. J Biol Chem. 1998;273:8153–60. doi: 10.1074/jbc.273.29.18153. [DOI] [PubMed] [Google Scholar]
  • 25.Repa JJ, Berge KE, Pomajzl C, et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem. 2002;277:18793–800. doi: 10.1074/jbc.M109927200. [DOI] [PubMed] [Google Scholar]
  • 26.Gartung C, Schuele S, Schlosser SF, et al. Expression of the rat liver Na+/taurocholate cotransporter is regulated in vivo by retention of biliary constituents but not their depletion. Hepatology. 1997;25:284–90. doi: 10.1002/hep.510250205. [DOI] [PubMed] [Google Scholar]
  • 27.Meijer GW, Demacker PN, Van Tol A, et al. Plasma activities of lecithin:cholesterol acyltransferase, lipid transfer proteins and post-heparin lipases in inbred strains of rabbits hypo- or hyper-responsive to dietary cholesterol. Biochem J. 1993;293:729–34. doi: 10.1042/bj2930729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Paigen B, Morrow A, Brandon C, et al. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 1985;57:65–73. doi: 10.1016/0021-9150(85)90138-8. [DOI] [PubMed] [Google Scholar]
  • 29.Van Zutphen LF, Den Bieman MG. Cholesterol response in inbred strains of rats, Rattus norvegicus. J Nutr. 1981;111:1833–8. doi: 10.1093/jn/111.10.1833. [DOI] [PubMed] [Google Scholar]
  • 30.Bhattacharyya AK, Eggen DA. Relationships between dietary cholesterol, cholesterol absorption, cholesterol synthesis, and plasma cholesterol in rhesus monkeys. Atherosclerosis. 1987;67:33–9. doi: 10.1016/0021-9150(87)90262-0. [DOI] [PubMed] [Google Scholar]
  • 31.McGill HC, Jr, McMahan CA, Mott GE, et al. Effects of selective breeding on the cholesterolemic responses to dietary saturated fat and cholesterol in baboons. Arteriosclerosis. 1988;8:33–9. doi: 10.1161/01.atv.8.1.33. [DOI] [PubMed] [Google Scholar]
  • 32.Kushwaha RS, McGill HC., Jr Diet, plasma lipoproteins and experimental atherosclerosis in baboons (Papio sp.) Hum Reprod Update. 1998;4:420–9. doi: 10.1093/humupd/4.4.420. [DOI] [PubMed] [Google Scholar]
  • 33.Katan MB, Beynen AC, de Vries JH, et al. Existence of consistent hypo- and hyperresponders to dietary cholesterol in man. Am J Epidemiol. 1986;123:221–34. doi: 10.1093/oxfordjournals.aje.a114231. [DOI] [PubMed] [Google Scholar]
  • 34.Denke MA, Grundy SM. Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia. Arch Intern Med. 1994;154:317–25. [PubMed] [Google Scholar]
  • 35.Kushwaha RS, McGill HC., Jr Mechanisms controlling lipemic responses to dietary lipids. World Rev Nutr Diet. 1997;80:82–125. doi: 10.1159/000059583. [DOI] [PubMed] [Google Scholar]
  • 36.Buhman KK, Accad M, Novak S, et al. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med. 2000;6:1341–7. doi: 10.1038/82153. [DOI] [PubMed] [Google Scholar]
  • 37.Levy E, Spahis S, Sinnett D, et al. Intestinal cholesterol transport proteins: an update and beyond. Curr Opin Lipidol. 2007;18:310–8. doi: 10.1097/MOL.0b013e32813fa2e2. [DOI] [PubMed] [Google Scholar]
  • 38.Kushwaha RS, Rosillo A, McGill HC., Jr Expression levels of genes for ATP-binding cassette transporters and sterol 27-hydroxylase in liver and intestine of baboons with high and low cholesterolemic responses to dietary lipids. J Med Primatol. 2005;34:122–9. doi: 10.1111/j.1600-0684.2005.00100.x. [DOI] [PubMed] [Google Scholar]

RESOURCES